Successful treatment of multicentric Castleman's disease with bilateral orbital tumour using rituximab [3]

British Journal of Haematology

Volumn 121, Issue 5, 2003, Pages 818-819

  Ide, Makoto ^a   Ogawa, Eiichi ^a   Kasagi, Kanji ^a   Kawachi, Yasunori ^a   Ogino, Tetsuro ^a  

^a TAKAMATSU RED CROSS HOSPITAL   (Japan)

Author keywords

Multicentric Castleman's disease; Rituximab

Indexed keywords

GALLIUM CITRATE GA 67; PREDNISOLONE; RITUXIMAB;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CASE REPORT; CELL TYPE; CLINICAL FEATURE; HUMAN; HUMAN TISSUE; LETTER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT TUMOR; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIDE EFFECT; SOUTHERN BLOTTING; TREATMENT OUTCOME; TUMOR BIOPSY;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; GIANT LYMPH NODE HYPERPLASIA; HUMANS; MALE; MIDDLE AGED; ORBITAL NEOPLASMS;

EID: 0038170372     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04358.x     Document Type: Letter

References (3)

1. Corbellino, M., Bestetti, G., Scalamogna, C., Calattini, S., Galazgi, M., Manganaro, D., Fasan, M., Moroni, M., Galli, M. & Parravicini, C. (2001) Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood, 98, 3473-3475.
2. Herrada, J., Cabanillas, F., Rice, L., Manning, J. & Pugh, W. (1998) The clinical behavior of localized and multicentric Castleman disease. Annals of Internal Medicine, 128, 657-662.
3. Nishimoto, N., Sasai, M., Shima, Y., Nakagawa, M., Matsumoto, T., Shirai, T., Kishimoto, T. & Yoshizaki, K. (2000) Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood, 95, 56-61.